Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1994 2
1995 2
1996 2
1999 1
2002 1
2007 1
2008 1
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial.
Ghadimi M, Pelzer U, Besselink MG, Siveke J, Telgmann R, Braren R, Wilmink H, Crede M, Koenig A, Koenig U, Liffers ST, Antweiler K, Uijterwijk B, Seppanen H, Nordin A, Puolakkainen P, Dajani OF, Labori KJ, Johansson M, Bratlie SO, Friede T, Jo P. Ghadimi M, et al. Among authors: dajani of. BMC Cancer. 2025 Feb 6;25(1):208. doi: 10.1186/s12885-025-13573-7. BMC Cancer. 2025. PMID: 39915735 Free PMC article.
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
Vagnildhaug OM, Balstad TR, Ottestad I, Bye A, Greil C, Arends J, Baracos V, Brown LR, Dajani OF, Dolan RD, Fallon M, Fraser E, Grzyb A, Hjermstad MJ, Jakobsen G, Kaasa S, McDonald J, Philips I, Sayers J, Simpson MR, Sousa MS, Skipworth RJE, Laird BJA, Solheim TS; Cancer Cachexia Endpoints Working Group. Vagnildhaug OM, et al. Among authors: dajani of. J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):513-535. doi: 10.1002/jcsm.13434. Epub 2024 Feb 11. J Cachexia Sarcopenia Muscle. 2024. PMID: 38343065 Free PMC article.
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
Hjermstad MJ, Jakobsen G, Arends J, Balstad TR, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OM, Laird BJA; Cancer Cachexia Endpoints Working Group. Hjermstad MJ, et al. Among authors: dajani of. J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):794-815. doi: 10.1002/jcsm.13453. Epub 2024 Mar 29. J Cachexia Sarcopenia Muscle. 2024. PMID: 38553255 Free PMC article.
Role of diacylglycerol (DAG) in hormonal induction of S phase in hepatocytes: the DAG-dependent protein kinase C pathway is not activated by epidermal growth factor (EGF), but is involved in mediating the enhancement of responsiveness to EGF by vasopressin, angiotensin II, and norepinephrine.
Dajani OF, Sandnes D, Melien O, Rezvani F, Nilssen LS, Thoresen GH, Christoffersen T. Dajani OF, et al. J Cell Physiol. 1999 Aug;180(2):203-14. doi: 10.1002/(SICI)1097-4652(199908)180:2<203::AID-JCP8>3.0.CO;2-T. J Cell Physiol. 1999. PMID: 10395290
Growth-promoting effects of Ca(2+)-mobilizing agents in hepatocytes: lack of correlation between the acute activation of phosphoinositide-specific phospholipase C and the stimulation of DNA synthesis by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2 alpha.
Dajani OF, Røttingen JA, Sandnes D, Horn RS, Refsnes M, Thoresen GH, Iversen JG, Christoffersen T. Dajani OF, et al. J Cell Physiol. 1996 Sep;168(3):608-17. doi: 10.1002/(SICI)1097-4652(199609)168:3<608::AID-JCP13>3.0.CO;2-V. J Cell Physiol. 1996. PMID: 8816915
17 results